Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.45 |
| ▸ | CTSK | P43235 | 3/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | CTSS | P25774 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | REN | P00797 | 2/20 | 0.44 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.43 |
| ▸ | PSEN2 | P49810 | 2/20 | 0.43 |
| ▸ | APH1B | Q8WW43 | 2/20 | 0.43 |
| ▸ | NCSTN | Q92542 | 2/20 | 0.43 |
| ▸ | APH1A | Q96BI3 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23969586 | 0.90 | REN (0.59) | CTSKCTSLCTSBCTSSMAPK1 | |
| SCHEMBL29356685 | 0.90 | REN (0.59) | CTSKCTSLCTSBCTSSMAPK1 | |
| SCHEMBL21848512 | 0.88 | PPARA (0.45) | ALDH1A1MAPTNPSR1KDM4EPLA2G1B | |
| SCHEMBL21834841 | 0.85 | CTSS (0.56) | CTSKCTSLCTSBCTSS | |
| SCHEMBL21848419 | 0.85 | HDAC4 (0.43) | ALDH1A1CTSKCTSLCTSBCTSS | |
| SCHEMBL30998336 | 0.84 | EPHX2 (0.45) | ALDH1A1MAPTKDM4EHPGDHTT | |
| SCHEMBL21848451 | 0.83 | EPHX2 (0.52) | ALDH1A1MAPTKDM4EHPGDCTSK | |
| SCHEMBL21848514 | 0.82 | PTPN1 (0.48) | CTSKCTSLCTSBCTSSREN | |
| SCHEMBL21848524 | 0.81 | CTSS (0.47) | CTSKCTSLCTSBCTSS | |
| SCHEMBL21848401 | 0.81 | CTSS (0.47) | CTSKCTSLCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357312-A1 | Borylated Di-Peptide Amino Acid compositions for use in Boron Neutron Capture Therapy and methods thereof | TAE LIFE SCIENCES LLC | 2023-11-09 | — | — | US | disclosed |
| WO-2023113843-A2 | BORYLATED DI-PEPTIDE AMINO ACID COMPOSITIONS FOR USE IN BORON NEUTRON CAPTURE THERAPY AND METHODS THEREOF | TAE Life Sciences (US) | 2023-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357312-A1 | Borylated Di-Peptide Amino Acid compositions for use in Boron Neutron Capture Therapy and methods thereof | NPPA, BCAT2, BCAT1 | ALDH1A1 4300/4885MAPT 2030/4885NPSR1 89/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.